ArticleOncogene2002

Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivo.

Achim Aigner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.